109 filings
8-K
MTNB
Matinas Biopharma Holdings Inc
9 May 24
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
4:06pm
8-K
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
8-K
MTNB
Matinas Biopharma Holdings Inc
28 Mar 24
Regulation FD Disclosure
9:00am
8-K
MTNB
Matinas Biopharma Holdings Inc
27 Mar 24
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
4:22pm
8-K
MTNB
Matinas Biopharma Holdings Inc
25 Mar 24
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
8:05am
8-K
5quimby2p9kso0gogbo
22 Mar 24
Regulation FD Disclosure
9:20am
8-K
elhb8kfg
22 Mar 24
Other Events
6:35am
8-K
n5rfxf
26 Feb 24
Regulation FD Disclosure
8:05am
8-K
o922 shbdhhgmbazlq8
20 Feb 24
Regulation FD Disclosure
7:35am
8-K
gvnocadwtuiaf3n
9 Jan 24
Regulation FD Disclosure
7:30am
8-K
za8 4ek8iw5pa3oup
27 Dec 23
In an acute psoriasis model, data show reductions in tissue IL-17A mRNA and improvement in clinical disease markers including skin lesions
7:40am
8-K
tpm s60c8n34zvibpe
21 Dec 23
Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA
7:40am
8-K
vayuyy40y 0s55xct
20 Nov 23
Regulation FD Disclosure
7:30am
8-K
r82u41ck r8ioyaci5pr
9 Nov 23
Matinas BioPharma Announces Positive in vivo Efficacy Results of Oral LNC Docetaxel Formulation in a Melanoma Model
5:25pm
8-K
37x27i05bsm6ybcy6g
8 Nov 23
Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
4:06pm
8-K
oa2zaehf892
2 Nov 23
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
4lkicxrbi7m kfpbx2bp
22 Sep 23
Matinas BioPharma Announces Notification of NYSE American Continued Listing Deficiency
5:25pm
8-K
xbrma vrtlka6pz
20 Sep 23
Regulation FD Disclosure
7:30am
8-K
9k0psgllj 2uk76c
9 Aug 23
Matinas BioPharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:06pm
8-K
hk7qhj nfef
10 May 23
Results of Operations and Financial Condition
4:05pm